{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:27:06Z","timestamp":1790616426084,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.dsx.2024.102973","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T18:01:00Z","timestamp":1709834460000},"page":"102973","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Prevalence and risk factors of MAFLD and its metabolic comorbidities in community-based adults in China: A cross-sectional study"],"prefix":"10.1016","volume":"18","author":[{"given":"Yajun","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanfang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualin","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genfeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qintao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6952-9541","authenticated-orcid":false,"given":"Jie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.dsx.2024.102973_bib1","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.dsx.2024.102973_bib2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dsx.2024.102973_bib3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12933-022-01697-0","article-title":"Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention","volume":"21","author":"Zhou","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"10.1016\/j.dsx.2024.102973_bib4","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/liv.14548","article-title":"Comparison of MAFLD and NAFLD diagnostic criteria in real world","volume":"40","author":"Lin","year":"2020","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.dsx.2024.102973_bib5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s12072-021-10157-y","article-title":"Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?","volume":"15","author":"Guerreiro","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.dsx.2024.102973_bib6","first-page":"1","article-title":"An international multidisciplinary consensus statement on MAFLD and the risk of CVD","author":"Zhou","year":"2023","journal-title":"Hepatol Int"},{"issue":"3","key":"10.1016\/j.dsx.2024.102973_bib7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.cgh.2021.11.038","article-title":"An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD","volume":"21","author":"Lim","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.dsx.2024.102973_bib8","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jhep.2021.01.019","article-title":"Hypertension in NAFLD: an uncontrolled burden","volume":"74","author":"Kasper","year":"2021","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.dsx.2024.102973_bib9","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.dsx.2020.11.015","article-title":"Nonalcoholic fatty liver disease should be considered for treatment allocation in standard management algorithms for type 2 diabetes","volume":"14","author":"Kuchay","year":"2020","journal-title":"Diabetes Metabol Syndr"},{"issue":"Suppl 2","key":"10.1016\/j.dsx.2024.102973_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.14521","article-title":"A clinical overview of non-alcoholic fatty liver disease: a guide to diagnosis, the clinical features, and complications-What the non-specialist needs to know","volume":"24","author":"Muthiah","year":"2022","journal-title":"Diabetes Obes Metabol"},{"issue":"4","key":"10.1016\/j.dsx.2024.102973_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.dsx.2024.102973_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155294","article-title":"Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: a data-driven cluster analysis with international validation","volume":"136","author":"Ye","year":"2022","journal-title":"Metabolism"},{"issue":"Suppl 1","key":"10.1016\/j.dsx.2024.102973_bib13","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.2337\/dc21-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021","volume":"44","author":"American Diabetes","year":"2021","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.dsx.2024.102973_bib14","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2013.168118","article-title":"Prevalence and control of diabetes in Chinese adults","volume":"310","author":"Xu","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.dsx.2024.102973_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2022.113257","article-title":"Chronic lead exposure induces fatty liver disease associated with the variations of gut microbiota","volume":"232","author":"Wan","year":"2022","journal-title":"Ecotoxicol Environ Saf"},{"issue":"3","key":"10.1016\/j.dsx.2024.102973_bib16","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00125-003-1031-x","article-title":"Occupational, commuting, and leisure-time physical activity in relation to risk for Type 2 diabetes in middle-aged Finnish men and women","volume":"46","author":"Hu","year":"2003","journal-title":"Diabetologia"},{"issue":"19","key":"10.1016\/j.dsx.2024.102973_bib17","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.dsx.2024.102973_bib18","first-page":"833","article-title":"Joint committee issued Chinese guideline for the management of dyslipidemia in a. [2016 Chinese guideline for the management of dyslipidemia in adults]","volume":"44","year":"2016","journal-title":"Zhonghua Xinxueguanbing Zazhi"},{"key":"10.1016\/j.dsx.2024.102973_bib19","article-title":"Prevalence of hyperuricemia among Chinese adults: findings from two nationally representative cross-sectional surveys in 2015-16 and 2018-19","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.dsx.2024.102973_bib20","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.dsx.2024.102973_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154752","article-title":"Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes","volume":"121","author":"Ciardullo","year":"2021","journal-title":"Metabolism"},{"issue":"10290","key":"10.1016\/j.dsx.2024.102973_bib22","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.dsx.2024.102973_bib23","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/hep.28584","article-title":"Global epidemiology of nonalcoholic fatty liver disease: meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Lonardo","year":"2016","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.dsx.2024.102973_bib24","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.dsx.2024.102973_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2020.12.022","article-title":"Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study","volume":"19","author":"Lee","year":"2021","journal-title":"Clin Gastroenterol Hepatol : the Official Clinical Practice Journal of the American Gastroenterological Association."},{"issue":"2","key":"10.1016\/j.dsx.2024.102973_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245762","article-title":"Outcomes of NAFLD and MAFLD: results from a community-based, prospective cohort study","volume":"16","author":"Niriella","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.dsx.2024.102973_bib27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12986-021-00611-x","article-title":"Prevalence and risk factors of metabolic associated fatty liver disease in the contemporary South China population","volume":"18","author":"Fan","year":"2021","journal-title":"Nutr Metabol"},{"issue":"4","key":"10.1016\/j.dsx.2024.102973_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19042096","article-title":"Prevalence and risk factors of metabolic-associated fatty liver disease among 73,566 individuals in Beijing, China","volume":"19","author":"Yuan","year":"2022","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.dsx.2024.102973_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1241169","article-title":"Sex-specific prevalence and risk factors of metabolic-associated fatty liver disease among 75,570 individuals in eastern China","volume":"14","author":"Chang","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.dsx.2024.102973_bib30","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2147\/DMSO.S292926","article-title":"Association between metabolic associated fatty liver disease and chronic kidney disease: a cross-sectional study from nhanes 2017-2018","volume":"14","author":"Deng","year":"2021","journal-title":"Diabetes, Metab Syndrome Obes Targets Ther"},{"key":"10.1016\/j.dsx.2024.102973_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1007171","article-title":"The prevalence of MAFLD and its association with atrial fibrillation in a nationwide health check-up population in China","volume":"13","author":"Lei","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.dsx.2024.102973_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol Metabol"},{"key":"10.1016\/j.dsx.2024.102973_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154868","article-title":"Diabetes and metabolic dysfunction-associated fatty liver disease","volume":"123","author":"Davis","year":"2021","journal-title":"Metab, Clin Exp"},{"key":"10.1016\/j.dsx.2024.102973_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.930224","article-title":"Associations of uric acid with liver steatosis and fibrosis applying vibration controlled transient elastography in the United States: a nationwide cross-section study","volume":"13","author":"Duan","year":"2022","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.dsx.2024.102973_bib35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00535-021-01759-2","article-title":"Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database","volume":"56","author":"Terai","year":"2021","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dsx.2024.102973_bib36","article-title":"Cardiovascular and renal burdens among patients with MAFLD and NAFLD in China","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.dsx.2024.102973_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s13679-019-0328-0","article-title":"Obesity in south asia: phenotype, morbidities, and mitigation","volume":"8","author":"Misra","year":"2019","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.dsx.2024.102973_bib38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.dsx.2024.102973_bib39","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American heart association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.dsx.2024.102973_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.773342","article-title":"Association between diabetes mellitus and all-cause and cardiovascular mortality among individuals with ultrasound-defined non-alcoholic fatty liver disease","volume":"12","author":"Wu","year":"2021","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.dsx.2024.102973_bib41","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.gastro.2022.06.023","article-title":"AGA clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals: expert review","volume":"163","author":"Long","year":"2022","journal-title":"Gastroenterology"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402124000341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402124000341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T17:09:58Z","timestamp":1716052198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402124000341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1871402124000341"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2024.102973","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and risk factors of MAFLD and its metabolic comorbidities in community-based adults in China: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2024.102973","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC). Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102973"}}